Home Cart Sign in  
Chemical Structure| 71470-41-2 Chemical Structure| 71470-41-2
Chemical Structure| 71470-41-2
Product Citations

Alternative Products

Product Details of [ 71470-41-2 ]

CAS No. :71470-41-2
Formula : C7H9N3O2
M.W : 167.17
SMILES Code : NC1=NC(=NC=C1)C(=O)OCC
MDL No. :MFCD11973676
InChI Key :YHDZCFILDSOJRF-UHFFFAOYSA-N
Pubchem ID :13060222

Safety of [ 71470-41-2 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Calculated chemistry of [ 71470-41-2 ] Show Less

Physicochemical Properties

Num. heavy atoms 12
Num. arom. heavy atoms 6
Fraction Csp3 0.29
Num. rotatable bonds 3
Num. H-bond acceptors 4.0
Num. H-bond donors 1.0
Molar Refractivity 42.52
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

78.1 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

1.49
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

0.41
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

0.24
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

-0.27
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

0.32
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

0.44

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-1.31
Solubility 8.25 mg/ml ; 0.0493 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-1.62
Solubility 4.04 mg/ml ; 0.0242 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-1.77
Solubility 2.86 mg/ml ; 0.0171 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

No
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-7.03 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

1.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

0.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

1.92
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 71470-41-2 ]

Esters

Chemical Structure| 42839-08-7

A238517 [42839-08-7]

Ethyl pyrimidine-2-carboxylate

Similarity: 0.94

Chemical Structure| 34253-03-7

A117964 [34253-03-7]

Methyl pyrimidine-2-carboxylate

Similarity: 0.90

Chemical Structure| 317334-58-0

A110924 [317334-58-0]

Methyl 4-methylpyrimidine-2-carboxylate

Similarity: 0.86

Chemical Structure| 76196-80-0

A282179 [76196-80-0]

Methyl 5-methylpyrimidine-2-carboxylate

Similarity: 0.84

Chemical Structure| 73418-88-9

A310213 [73418-88-9]

Methyl 5-aminopyrimidine-2-carboxylate

Similarity: 0.84

Amines

Chemical Structure| 73418-88-9

A310213 [73418-88-9]

Methyl 5-aminopyrimidine-2-carboxylate

Similarity: 0.84

Chemical Structure| 56621-98-8

A241369 [56621-98-8]

5-Aminopyrimidine-2-carboxylic acid

Similarity: 0.76

Chemical Structure| 1355074-03-1

A418376 [1355074-03-1]

5-Ethoxypyrimidin-4-amine

Similarity: 0.61

Chemical Structure| 695-86-3

A120252 [695-86-3]

5-Methoxypyrimidin-4-amine

Similarity: 0.61

Chemical Structure| N/A

A122333 [N/A]

Methyl 5-amino-1H-benzo[d]imidazole-2-carboxylate hydrochloride-Deleted-NAME

Similarity: 0.59

Related Parent Nucleus of
[ 71470-41-2 ]

Pyrimidines

Chemical Structure| 42839-08-7

A238517 [42839-08-7]

Ethyl pyrimidine-2-carboxylate

Similarity: 0.94

Chemical Structure| 34253-03-7

A117964 [34253-03-7]

Methyl pyrimidine-2-carboxylate

Similarity: 0.90

Chemical Structure| 317334-58-0

A110924 [317334-58-0]

Methyl 4-methylpyrimidine-2-carboxylate

Similarity: 0.86

Chemical Structure| 76196-80-0

A282179 [76196-80-0]

Methyl 5-methylpyrimidine-2-carboxylate

Similarity: 0.84

Chemical Structure| 73418-88-9

A310213 [73418-88-9]

Methyl 5-aminopyrimidine-2-carboxylate

Similarity: 0.84